Cargando…

Xanthine Oxidase Inhibitors for Improving Renal Function in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis

Background: Accruing evidence suggests that Xanthine Oxidase inhibitors (XOis) may bring direct renal benefits, besides those related to their hypo-uricemic effect. We hence aimed at performing a systematic review of randomized controlled trials (RCTs) to verify if treatment with XOis may improve re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisano, Anna, Cernaro, Valeria, Gembillo, Guido, D’Arrigo, Graziella, Buemi, Michele, Bolignano, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713253/ https://www.ncbi.nlm.nih.gov/pubmed/29088122 http://dx.doi.org/10.3390/ijms18112283

Ejemplares similares

Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis
por: Bolignano, Davide, et al.
Publicado: (2017)

Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis
por: Pisano, Anna, et al.
Publicado: (2018)

Pentoxifylline for Anemia in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Bolignano, Davide, et al.
Publicado: (2015)

Role of Vitamin D Status in Diabetic Patients with Renal Disease
por: Gembillo, Guido, et al.
Publicado: (2019)

Xanthine oxidase inhibitors and sepsis
por: Ramos, Maria Fátima de Paula, et al.
Publicado: (2018)

Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review
por: Abd ElHafeez, Samar, et al.
Publicado: (2018)

Protective Role of Vitamin D in Renal Tubulopathies
por: Gembillo, Guido, et al.
Publicado: (2020)

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
por: Cernaro, Valeria, et al.
Publicado: (2016)

Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease
por: Visconti, Luca, et al.
Publicado: (2016)

Renoprotective Effect of Xanthine Oxidase Inhibitor, Topiroxostat
por: Katsuyama, Hisayuki, et al.
Publicado: (2019)

Xanthine oxidase inhibitors in ischaemic heart disease
por: Zdrenghea, Mihnea, et al.
Publicado: (2017)

Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist’s Opinion
por: Gembillo, Guido, et al.
Publicado: (2020)

Structure–Activity Relationship of Xanthones as Inhibitors of Xanthine Oxidase
por: Zhou, Ling-Yun, et al.
Publicado: (2018)

Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
por: Jordan, Andreas, et al.
Publicado: (2018)

Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease
por: Calabrese, Vincenzo, et al.
Publicado: (2022)

Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis
por: Zhang, Jufen, et al.
Publicado: (2016)

Structure–activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
por: Vitale, Rosa Maria, et al.
Publicado: (2017)

The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
por: Ryu, Dong-Ryeol
Publicado: (2017)

Identification of xanthine oxidase inhibitors through hierarchical virtual screening
por: Yang, Ying, et al.
Publicado: (2020)

Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
por: Saito, Hirotaka, et al.
Publicado: (2021)

Oxidized Resveratrol Metabolites as Potent Antioxidants and Xanthine Oxidase Inhibitors
por: Agbadua, Orinamhe G., et al.
Publicado: (2022)

Inhibition of Xanthine Oxidase Protects against Sepsis-Induced Acute Kidney Injury by Ameliorating Renal Hypoxia
por: Wang, Ting-ting, et al.
Publicado: (2022)

XANTHINE OXIDASE ACTIVITY IN REGENERATING LIVER
por: Feigelson, Muriel, et al.
Publicado: (1957)

Study of Drug Metabolism by Xanthine Oxidase
por: Zhao, Jing, et al.
Publicado: (2012)

Xanthine Oxidase—A Personal History
por: Hille, Russ
Publicado: (2023)

Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia
por: Omizo, Hiroki, et al.
Publicado: (2020)

Characterization of an Anti-gout Xanthine Oxidase Inhibitor from Pleurotus ostreatus
por: Jang, In-Taek, et al.
Publicado: (2014)

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy
por: Perez-Ruiz, Fernando, et al.
Publicado: (2019)

Screening and Evaluation of Xanthine Oxidase Inhibitors from Gnetum parvifolium in China
por: Tang, Xiaosheng, et al.
Publicado: (2019)

In silico design and synthesis of hesperitin derivatives as new xanthine oxidase inhibitors
por: Malik, Neelam, et al.
Publicado: (2019)

In silico design and synthesis of targeted rutin derivatives as xanthine oxidase inhibitors
por: Malik, Neelam, et al.
Publicado: (2019)

Bis-thiobarbiturates as Promising Xanthine Oxidase Inhibitors: Synthesis and Biological Evaluation
por: Serrano, João L., et al.
Publicado: (2021)

Phloroglucinol Derivatives from Dryopteris crassirhizoma as Potent Xanthine Oxidase Inhibitors
por: Yuk, Heung Joo, et al.
Publicado: (2020)

The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2
por: Higa, Yoshiki, et al.
Publicado: (2023)

Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme
por: Rullo, Rosario, et al.
Publicado: (2023)

Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
por: Tayama, Yoshitaka, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine
por: Longhitano, Elisa, et al.
Publicado: (2023)

Natural Xanthine Oxidase Inhibitor 5-O-Caffeoylshikimic Acid Ameliorates Kidney Injury Caused by Hyperuricemia in Mice
por: Zhang, Dong, et al.
Publicado: (2021)

The mechanism and significance of the conversion of xanthine dehydrogenase to xanthine oxidase in mammalian secretory gland cells
por: Kusano, Teruo, et al.
Publicado: (2022)

Efficacy of Xanthine Oxidase Inhibitors in Lowering Serum Uric Acid in Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Lee, Yoojin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_evc7lg8jrvhj5muchpjbbbs1jv